Conference
A multicenter, phase II study of cisplatin, irinotecan and epirubicin (PIE) administered every 3 weeks in patients with unresectable, locally advanced/metastatic cervical carcinoma
Authors
Townsley CA; Elit L; Sturgeon J; Carey M; Tinker L; Afinec A; Oza AM
Volume
16
Pagination
pp. 296-297
Publisher
OXFORD UNIV PRESS
Publication Date
January 1, 2005
Name of conference
ESMO Scientific and Educational Conference (ESEC)
Conference place
Budapest, HUNGARY
Conference start date
June 2, 2005
Conference end date
June 5, 2005
Conference proceedings
ANNALS OF ONCOLOGY
ISSN
0923-7534